Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 September 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 189 pages)

 

Export 199 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
I. Tamimi, Nicolau, B., Eimar, H., S. Madathil, A., Kezouh, A., Karp, I., and Tamimi, F., Acetylcholinesterase inhibitors and the risk of osteoporotic fractures: nested case-control study, Osteoporos Int, vol. 29, pp. 849-857, 2018.
S. V. Eastwood, Mathur, R., Atkinson, M., Brophy, S., Sudlow, C., Flaig, R., de Lusignan, S., Allen, N., and Chaturvedi, N., Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank, PLoS One, vol. 11, p. e0162388, 2016.
B. M. Hicks, Yin, H., Bladou, F., Ernst, P., and Azoulay, L., Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia, Thorax, vol. 72, pp. 596-597, 2017.
K. Bhaskaran, Douglas, I., Evans, S., Van Staa, T., and Smeeth, L., Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database, Bmj, vol. 344, p. e2697, 2012.
K. L. Goh, Bhaskaran, K., Minassian, C., Evans, S. J., Smeeth, L., and Douglas, I. J., Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink, Br J Clin Pharmacol, vol. 79, pp. 337-50, 2015.
I. Essers, Stolwijk, C., Boonen, A., De Bruin, M. L., Bazelier, M. T., de Vries, F., and van Tubergen, A., Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study, Ann Rheum Dis, vol. 75, pp. 203-9, 2016.
V. Abbing-Karahagopian, Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., Alvarez, Y., Miret, M., Gil, M., Oliva, B., Hesse, U., Requena, G., de Vries, F., Rottenkolber, M., Schmiedl, S., Reynolds, R., Schlienger, R. G., de Groot, M. C., Klungel, O. H., van Staa, T. P., van Dijk, L., Egberts, A. C., Gardarsdottir, H., and De Bruin, M. L., Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications, Eur J Clin Pharmacol, vol. 70, pp. 849-57, 2014.
C. Martinez, Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S., and Gunnell, D., Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study, Bmj, vol. 330, p. 389, 2005.
J. H. Flory, Ellenberg, S., Szapary, P. O., Strom, B. L., and Hennessy, S., Antidiabetic action of bezafibrate in a large observational database, Diabetes Care, vol. 32, pp. 547-51, 2009.
R. Charlton, Garne, E., Wang, H., Klungsoyr, K., Jordan, S., Neville, A., Pierini, A., Hansen, A., Engeland, A., Gini, R., Thayer, D., Bos, J., Puccini, A., Andersen, A. M. Nybo, Dolk, H., and L. van den Berg, deJong-, Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions, Pharmacoepidemiol Drug Saf, vol. 24, pp. 1144-54, 2015.
C. Klop, Gibson-Smith, D., Elders, P. J., Welsing, P. M., Leufkens, H. G., Harvey, N. C., Bijlsma, J. W., van Staa, T. P., and de Vries, F., Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010, Osteoporos Int, vol. 26, pp. 1919-28, 2015.
R. J. Pitman, Melegaro, A., Gelb, D., Siddiqui, M. R., Gay, N. J., and Edmunds, W. J., Assessing the burden of influenza and other respiratory infections in England and Wales, J Infect, vol. 54, pp. 530-8, 2007.
S. Hajat, Haines, A., Atkinson, R. W., Bremner, S. A., Anderson, H. R., and Emberlin, J., Association between air pollution and daily consultations with general practitioners for allergic rhinitis in London, United Kingdom, Am J Epidemiol, vol. 153, pp. 704-14, 2001.
V. Sazonov, Beetsch, J., Phatak, H., Wentworth, C., and Evans, M., Association between dyslipidemia and vascular events in patients treated with statins: report from the UK General Practice Research Database, Atherosclerosis, vol. 208, pp. 210-6, 2010.
S. Hawley, Cordtz, R., Dreyer, L., Edwards, C. J., Arden, N. K., Delmestri, A., Silman, A., Cooper, C., Judge, A., and Prieto-Alhambra, D., Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis, Semin Arthritis Rheum, vol. 47, pp. 605-610, 2018.
Y. M. F. Andersen, Egeberg, A., Ban, L., Gran, S., Williams, H. C., Francis, N. A., Knop, F. K., Gislason, G. H., Skov, L., and Thyssen, J. P., Association Between Topical Corticosteroid Use and Type 2 Diabetes in Two European Population-Based Adult Cohorts, Diabetes Care, vol. 42, pp. 1095-1103, 2019.
J. Browne, Edwards, D. A., Rhodes, K. M., Brimicombe, D. J., and Payne, R. A., Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study, BMJ Open, vol. 7, p. e012546, 2017.
R. A. Charlton, Pierini, A., Klungsoyr, K., Neville, A. J., Jordan, S., van den Berg, L. T. de Jong, Thayer, D., Bos, H. J., Puccini, A., Hansen, A. V., Gini, R., Engeland, A., Andersen, A. M. Nybo, Dolk, H., and Garne, E., Asthma medication prescribing before, during and after pregnancy: a study in seven European regions, BMJ Open, vol. 6, p. e009237, 2016.
B
C. R. Cardwell, Coleman, H. G., Murray, L. J., Entschladen, F., and Powe, D. G., Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort, Int J Epidemiol, vol. 42, pp. 1852-61, 2013.
C. A. Emdin, Rothwell, P. M., Salimi-Khorshidi, G., Kiran, A., Conrad, N., Callender, T., Mehta, Z., Pendlebury, S. T., Anderson, S. G., Mohseni, H., Woodward, M., and Rahimi, K., Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke, Stroke, vol. 47, pp. 1429-35, 2016.
N. Qizilbash, Gregson, J., Johnson, M. E., Pearce, N., Douglas, I., Wing, K., Evans, S. J. W., and Pocock, S. J., BMI and risk of dementia in two million people over two decades: a retrospective cohort study, Lancet Diabetes Endocrinol, vol. 3, pp. 431-436, 2015.
V. Abbing-Karahagopian, Kurz, X., de Vries, F., van Staa, T. P., Alvarez, Y., Hesse, U., Hasford, J., Dijk, L., de Abajo, F. J., Weil, J. G., Grimaldi-Bensouda, L., Egberts, A. C., Reynolds, R. F., and Klungel, O. H., Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project, Curr Clin Pharmacol, vol. 9, pp. 130-8, 2014.
E. A. Yanni, Ferreira, G., Guennec, M., Y. Hahi, E., A. Ghachi, E., Haguinet, F., Espie, E., and Bianco, V., Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012, BMJ Open, vol. 8, p. e020528, 2018.
C
A. Judge, Wallace, G., Prieto-Alhambra, D., Arden, N. K., and Edwards, C. J., Can the publication of guidelines change the management of early rheumatoid arthritis? An interrupted time series analysis from the United Kingdom, Rheumatology (Oxford), vol. 54, pp. 2244-8, 2015.
A. But, De Bruin, M. L., Bazelier, M. T., Hjellvik, V., Andersen, M., Auvinen, A., Starup-Linde, J., Schmidt, M. K., Furu, K., de Vries, F., Karlstad, O., Ekstrom, N., and Haukka, J., Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study, Diabetologia, vol. 60, pp. 1691-1703, 2017.
A. K. Wright, Kontopantelis, E., Emsley, R., Buchan, I. E., Mamas, M. A., Sattar, N., Ashcroft, D. M., and Rutter, M. K., Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes: A Population-Based Cohort Study Assessing Sex Disparities, Circulation, 2019.
C. J. Edwards, Arden, N. K., Fisher, D., Saperia, J. C., Reading, I., van Staa, T. P., and Cooper, C., The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database, Rheumatology (Oxford), vol. 44, pp. 1394-8, 2005.
A. I. B. Kurdi, Elliott, R. A., and Chen, L. C., Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors: a population-based study, J Hypertens, 2018.
A. Berger, Sadosky, A., Dukes, E., Edelsberg, J., and Oster, G., Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study, BMC Neurol, vol. 12, p. 8, 2012.
C. Miani, Martin, A., Exley, J., Doble, B., Wilson, E., Payne, R., Avery, A., Meads, C., Kirtley, A., Jones, M. M., and King, S., Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling, Health Technol Assess, vol. 21, pp. 1-128, 2017.
I. J. Douglas, Evans, S. J., Hingorani, A. D., Grosso, A. M., Timmis, A., Hemingway, H., and Smeeth, L., Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs, Bmj, vol. 345, p. e4388, 2012.
R. Boggon, van Staa, T. P., Timmis, A., Hemingway, H., Ray, K. K., Begg, A., Emmas, C., and Fox, K. A., Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction–a hospital registry-primary care linked cohort (MINAP-GPRD), Eur Heart J, vol. 32, pp. 2376-86, 2011.
A. Bakhai, Rigney, U., Hollis, S., and Emmas, C., Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population, Pharmacoepidemiol Drug Saf, vol. 21, pp. 485-93, 2012.
S. Suissa, Dell'Aniello, S., and Ernst, P., Comparative effectiveness and safety of LABA-LAMA versus LABA-ICS treatment of COPD in real world clinical practice, Chest, 2019.
S. Suissa, Dell'Aniello, S., and Ernst, P., Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study, Lancet Respir Med, vol. 6, pp. 855-862, 2018.
S. S. Zghebi, Steinke, D. T., Rutter, M. K., Emsley, R. A., and Ashcroft, D. M., Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records, Diabetes Obes Metab, vol. 18, pp. 916-24, 2016.
L. Hassan, Senior, J., Frisher, M., Edge, D., and Shaw, J., A comparison of psychotropic medication prescribing patterns in East of England prisons and the general population, J Psychopharmacol, vol. 28, pp. 357-62, 2014.
D. M. Fleming, Ross, A. M., Cross, K. W., Kendall, H., and Elliot, A. J., Concerning: 'Why has antibiotic prescribing for respiratory illness declined in primary care? A longitudinal study using the General Practice Research Database', J Public Health (Oxf), vol. 27, pp. 228-9; author reply 229-31, 2005.
Y. Lis, Spitzer, W. O., Mann, R. D., Chukwujindu, J., Thorogood, M., Evans, S., Suissa, S., and Lelorier, J., A concurrent cohort study of oral contraceptive users from the VAMP research bank, Pharmacoepidemiology and Drug Safety, vol. 2, pp. 51-63, 1993.
S. Suissa, Dell'Aniello, S., and Ernst, P., Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events, Eur Respir J, vol. 49, 2017.
R. Boggon, Eaton, S., Timmis, A., Hemingway, H., Gabriel, H., Minhas, I., and van Staa, T. P., Current prescribing of statins and persistence to statins following ACS in the UK: a MINAP/GPRD study, Br J Cardiol, vol. 19, p. 24, 2012.
D
J. Wilding, Bailey, C., Rigney, U., Blak, B., Kok, M., and Emmas, C., Dapagliflozin therapy for type 2 diabetes in primary care: Changes in HbA1c, weight and blood pressure over 2 years follow-up, Prim Care Diabetes, vol. 11, pp. 437-444, 2017.
T. Fundament, Eldridge, P. R., Green, A. L., Whone, A. L., Taylor, R. S., Williams, A. C., and Schuepbach, W. M., Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis, PLoS One, vol. 11, p. e0159340, 2016.
M. E. Saine, Carbonari, D. M., Newcomb, C. W., Nezamzadeh, M. S., Haynes, K., Roy, J. A., Cardillo, S., Hennessy, S., Holick, C. N., Esposito, D. B., Gallagher, A. M., Bhullar, H., Strom, B. L., and , Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs, BMC Pharmacol Toxicol, vol. 16, p. 8, 2015.
T. A. Hammad, Margulis, A. V., Ding, Y., Strazzeri, M. M., and Epperly, H., Determining the predictive value of Read codes to identify congenital cardiac malformations in the UK Clinical Practice Research Datalink, Pharmacoepidemiol Drug Saf, vol. 22, pp. 1233-8, 2013.
D. Yu, Jordan, K. P., Snell, K. I. E., Riley, R. D., Bedson, J., Edwards, J. J., Mallen, C. D., Tan, V., Ukachukwu, V., Prieto-Alhambra, D., Walker, C., and Peat, G., Development and validation of prediction models to estimate risk of primary total hip and knee replacements using data from the UK: two prospective open cohorts using the UK Clinical Practice Research Datalink, Ann Rheum Dis, 2018.
B. M. Verdel, Souverein, P. C., Egberts, A. C., and Leufkens, H. G., Difference in risks of allergic reaction to sulfonamide drugs based on chemical structure, Ann Pharmacother, vol. 40, pp. 1040-6, 2006.
J. L. Faillie, Filion, K. B., Patenaude, V., Ernst, P., and Azoulay, L., Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes, Diabetes Obes Metab, vol. 17, pp. 379-85, 2015.
[Page last reviewed 6 September 2019]